Literature DB >> 82538

Developmental changes in carbohydrate moiety of human alpha-fetoprotein.

E Ruoslahti, E Engvall, A Pekkala, M Seppälä.   

Abstract

Human AFP purified from fetal serum and amniotic fluid was separated into three different variants by chromatography on concanavalin A insolubilized on Sepharose (Con A--Sepharose). The three variants were indistinguishable in immunodiffusion and radioimmunoassay. Sera from patients with yolk-sac tumor and amniotic fluid from early pregnancy were found to contain a high proportion (15-45%) of AFP which does not bind to Con A, while AFP in fetal and newborn sera, and in amniotic fluid from late pregnancy, contained less (2-6%) of this variant. The use of a large excess of Con A--Sepharose and the fact that the non-bound AFP consistently eluted as non-bound in rechromatography showed that this AFP is non-reactive with Con A. Fractionation of radiolabelled AFP from cord serum in a mixture with amniotic fluid verified the difference in the amount of the Con-A nonreactive variant in AFP from these two sources. These results suggest that AFP synthesized by the yolk-sac tissue and by the liver are glycosylated differently. The variant may prove to be diagnostically useful.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82538     DOI: 10.1002/ijc.2910220502

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Concanavalin A--non-reactive alpha-fetoprotein and communicating fetal malformation.

Authors:  P C Kelleher; C J Smith
Journal:  Br Med J       Date:  1979-11-03

2.  Determination of subfractions of amniotic fluid alpha-fetoprotein in diagnosing spina bifida and congenital nephrosis.

Authors:  E Ruoslahti; A Pekkala; D E Comings; M Seppålå
Journal:  Br Med J       Date:  1979-09-29

3.  Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy.

Authors:  P K Buamah; C Cornell; O F James; A W Skillen; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.

Authors:  T Ishiguro; H Sakaguchi; M Fukui; I Sugitachi
Journal:  Jpn J Surg       Date:  1986-01

Review 5.  Alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9-producing gallbladder cancer.

Authors:  T Ono; M Komatsu; T Hoshino; T Ishii; T Fujii; S Oshima; K Mikami; Y Umeki; K Enomoto; O Masamune
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

Review 6.  Hepatoid adenocarcinoma: a distinctive histological subtype of alpha-fetoprotein-producing lung carcinoma.

Authors:  H Ishikura; M Kanda; M Ito; K Nosaka; K Mizuno
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

7.  Correlation between the alpha 1-fetoprotein (AFP) concentrations determined in the sera and in the tumour tissues in patients with testicular tumours.

Authors:  H Kosmehl; G Stadie; B Szöke; M Schulze
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 8.  Management of fetal teratomas.

Authors:  Jose L Peiró; Lourenço Sbragia; Federico Scorletti; Foong Y Lim; Aimen Shaaban
Journal:  Pediatr Surg Int       Date:  2016-04-25       Impact factor: 1.827

Review 9.  Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.

Authors:  Y Aoyagi
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

10.  Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.

Authors:  Y Aoyagi; Y Suzuki; K Igarashi; A Saitoh; M Oguro; T Yokota; S Mori; T Suda; M Isemura; H Asakura
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.